Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy.
Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell LK, Jiang S, Murphy JD.
Li Y, et al. Among authors: mell lk.
Med Dosim. 2015 Winter;40(4):318-24. doi: 10.1016/j.meddos.2015.04.002. Epub 2015 May 19.
Med Dosim. 2015.
PMID: 26002122